Okomera secures €1.5M grant to advance microfluidics and AI-powered CRISPR editing for target validation
Okomera announces Bpifrance funding to develop and standardize novel CRISPR screening assay to accelerate drug discovery in oncology with leading cancer research center of Marseille, CRCM.